Evaluation of Radiolabeled (Hetero)Aromatic Analogues of <i>N</i>-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma
作者:Jean-Michel Chezal、Janine Papon、Pierre Labarre、Claire Lartigue、Marie-Josephe Galmier、Caroline Decombat、Olivier Chavignon、Jean Maublant、Jean-Claude Teulade、Jean-Claude Madelmont、Nicole Moins
DOI:10.1021/jm701424g
日期:2008.6.1
discovered. Targeted radionuclide therapy concentrates the effects on tumor cells, thereby increasing the efficacy and decreasing the morbidity of radiotherapy. In this context, analogues of N-(2-diethylaminoethyl)-4-iodobenzamide (BZA) are of interest. Various (hetero)aromatic analogues 5 of BZA were synthesized and radioiodinated with (125)I, and their biodistribution in melanoma-bearing mice was studied
使用对黑素瘤组织具有特定亲和力的放射性碘化化合物的靶向放射性核素治疗是弥散性黑素瘤的一种有前途的治疗方法,但具有理想动力学特征的候选药物仍有待发现。靶向放射性核素疗法集中了对肿瘤细胞的作用,从而提高了疗效并降低了放射疗法的发病率。在这种情况下,N-(2-二乙基氨基乙基)-4-碘代苯甲酰胺(BZA)的类似物是令人关注的。合成了多种BZA的(杂)芳族类似物5并用(125)I进行了放射性碘标记,并在静脉注射后研究了它们在荷黑素瘤小鼠中的生物分布。大多数[(125)I] 5标记的化合物似乎与黑素瘤肿瘤特异性结合并且具有中到高亲和力。5h和5k这两种化合物,